α-Glycosidase-IN-1
Modify Date: 2024-01-08 12:41:50
α-Glycosidase-IN-1 structure
|
Common Name | α-Glycosidase-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 2428389-66-4 | Molecular Weight | 557.56 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H19N9O6S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of α-Glycosidase-IN-1α-Glycosidase-IN-1 (compound MZ7) is a potent α-GLY (α-Glycosidase) inhibitor, with an IC50 of 44.72 nM and a KI of 41.74 nM. α-Glycosidase-IN-1 also shows inhibition profile against human carbonic anhydrase isoenzymes I and II (hCA I and hCA II), and acetylcholinesterase (AChE), with IC50 values of 104.87, 100.04, and 654.87 nM, respectively. α-Glycosidase-IN-1 can be used for the research of many diseases such as diabetes, Alzheimer’s disease, heart failure, ulcer, and epilepsy[1]. |
| Name | α-Glycosidase-IN-1 |
|---|
| Description | α-Glycosidase-IN-1 (compound MZ7) is a potent α-GLY (α-Glycosidase) inhibitor, with an IC50 of 44.72 nM and a KI of 41.74 nM. α-Glycosidase-IN-1 also shows inhibition profile against human carbonic anhydrase isoenzymes I and II (hCA I and hCA II), and acetylcholinesterase (AChE), with IC50 values of 104.87, 100.04, and 654.87 nM, respectively. α-Glycosidase-IN-1 can be used for the research of many diseases such as diabetes, Alzheimer’s disease, heart failure, ulcer, and epilepsy[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 44.72 ± 0.9964 nM (α-GLY), 100.04 ± 0.9688 nM (hCA II), 104.87 ± 0.9920 nM (hCA I), 654.87 ± 0.9383 nM (AChE); KI: 41.74 ± 8.08 nM (α-GLY), 114.78 ± 20.33 nM (hCA I), 114.78 ± 9.54 nM (hCA II), 597.33 ± 100.56 nM (AChE)[1] |
| References |
| Molecular Formula | C21H19N9O6S2 |
|---|---|
| Molecular Weight | 557.56 |